Entering text into the input field will update the search result below

Celldex beats by $0.02, beats on revenue

Aug. 08, 2016 4:05 PM ETCelldex Therapeutics, Inc. (CLDX) StockBy: Mohit Manghnani, SA News Editor6 Comments
  • Celldex (NASDAQ:CLDX): Q2 EPS of -$0.32 beats by $0.02.
  • Revenue of $1.4M (-35.8% Y/Y) beats by $0.55M.
  • Press Release

Recommended For You

About CLDX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CLDX--
Celldex Therapeutics, Inc.